Pneumonitis complicating methotrexate therapy for pustular psoriasis

被引：11
|
作者：
Ameen, M
Taylor, DA
Williams, IP
Wells, AU
Barker, JNWN
机构：
[1] St Thomas Hosp, St Johns Inst Dermatol, London SE1 7EH, England
[2] Hemel Hempstead Gen Hosp, Dept Thorac Med, Hempstead, Herts, England
[3] Royal Brompton Natl Heart & Lung Hosp, London SW3 6NP, England
来源：
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY | 2001年 / 15卷 / 03期
关键词：
methotrexate; pneumonitis; psoriasis;
D O I：
10.1046/j.1468-3083.2001.t01-1-00223.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a patient with pustular psoriasis who developed interstitial pneumonitis after receiving weekly methotrexate (MTX) therapy at an average dose of 20 mg for 26 years. The patient responded dramatically to withdrawal of the drug and administration of corticosteroids. Pulmonary toxicity is a rare adverse effect of MTX therapy and is particularly uncommon in psoriatics. As interstitial pneumonitis is a potentially fatal but reversible complication, early respiratory symptoms even in patients on low-dose MTX treatment should be appropriately investigated.
引用
收藏
页码：247 / 249
页数：3
相关论文
共 50 条
  • [21] Systemic methotrexate therapy for psoriasis: past, present and future
    Dogra, S.
    Mahajan, R.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2013, 38 (06) : 573 - 588
  • [22] Use of methotrexate in patients with psoriasis
    Kuhn, A.
    Ruland, V.
    Patsinakidis, N.
    Luger, T. A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2010, 28 (05) : S138 - S144
  • [23] Association of the characteristics of the blood metabolome and gut microbiome with the outcome of methotrexate therapy in psoriasis
    Qiu, Qinwei
    Deng, Jingwen
    Deng, Hao
    Yao, Danni
    Yan, Yuhong
    Ye, Shuyan
    Shang, Xiaoxiao
    Deng, Yusheng
    Han, Lijuan
    Zheng, Guangjuan
    Roy, Bhaskar
    Chen, Yang
    Han, Ling
    Huang, Runyue
    Fang, Xiaodong
    Lu, Chuanjian
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [24] Combined acitretin-methotrexate therapy seems safe and efficient in children with psoriasis
    Ariane, M.
    Mahe, E.
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2022, 149 (03): : 189 - 190
  • [25] Guidelines on the Use of Methotrexate in Psoriasis
    Carretero, G.
    Puig, L.
    Dehesa, L.
    Carrascosa, J. M.
    Ribera, M.
    Sanchez-Regana, M.
    Dauden, E.
    Vidal, D.
    Alsina, M.
    Munoz-Santos, C.
    Lopez-Estebaranz, J. L.
    Notario, J.
    Ferrandiz, C.
    Vanaclocha, F.
    Garcia-Bustinduy, M.
    Taberner, R.
    Belinchon, I.
    Sanchez-Carazo, J.
    Moreno, J. C.
    ACTAS DERMO-SIFILIOGRAFICAS, 2010, 101 (07): : 600 - 613
  • [26] Pulmonary lymphoma developed during long-term methotrexate therapy for psoriasis
    Suzuki, Manabu
    Hirano, Satoshi
    Ito, Hideyuki
    Matsubara, Daisuke
    Kubota, Kazuo
    Takeda, Yuichiro
    Sugiyama, Haruhito
    Kobayashi, Nobuyuki
    Kudo, Koichiro
    RESPIROLOGY, 2007, 12 (05) : 774 - 776
  • [27] Systemic methotrexate for the treatment of psoriasis
    Yelamos, Oriol
    Puig, Lluis
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (05) : 553 - 563
  • [28] Rapidly Fatal Acute ATLL Emerging After Methotrexate Therapy for Disseminated Psoriasis
    Dasanu, Constantin A.
    Bauer, Frank
    Ichim, Thomas E.
    Vyas, Dhwanil
    Ek, Kirsten
    Alexandrescu, Doru T.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (01) : 76 - 78
  • [29] Pustular psoriasis of intertriginous areas
    Reich, Adam
    PRZEGLAD DERMATOLOGICZNY, 2012, 99 (01): : 35 - 38
  • [30] Methotrexate Pneumonitis in Rheumatoid Arthritis: A Case Report
    Herrera Cespedes, Cristhian Emilio
    Gonzalez Aviles, Catalina
    Garcia Morales, Olga Milena
    Prieto Campos, Pierangely
    UNIVERSITAS MEDICA, 2022, 63 (02):
12345